Life Insurance
Consensus Index

AI Consensus Fit Review

John Hancock Life Insurance Fit Review for People With Heart Disease

John Hancock is a mixed fit for Life Insurance for People With Heart Disease.

Research: 2026-09-227 usable platform responsesRead the methodology ↗

Share

Answer Capsule

John Hancock is a mixed fit for Life Insurance for People With Heart Disease. Five of the seven platforms named John Hancock during the ranking stage, and it finished with an average listed rank of 3.2 and a best rank of 3. The strongest reason to consider it is its medically underwritten term and permanent coverage, which can evaluate an actual cardiac history case by case rather than applying a blanket cardiac denial, plus a Vitality wellness program that may reward healthy behaviors. The main limitation is that John Hancock publishes no cardiac-specific acceptance rules or rates, its simplified-issue Simple Term with Vitality product excludes major heart-disease histories, and pricing and eligibility stay uncertain until full medical underwriting is complete.

Research Snapshot

FieldDetail
Platform mentions in ranking stage5 of 7 platforms (deepseek, grok, kimi, openai, perplexity)
Share of included platform responses71.4%
Average listed rank3.2
Best listed rank3
Relevant product/model/planMedically underwritten John Hancock term life insurance (including Vitality Term) or permanent life insurance (Protection UL), often with optional John Hancock Vitality, sold through a licensed agent or independent broker
Overall use-case fitMixed
Research date2026-09-22

Why John Hancock Qualified for This Study

Questions This Section Answers

  • Is John Hancock a good choice for life insurance for people with heart disease?
  • How many AI platforms named John Hancock for heart disease life insurance, and at what rank?

John Hancock qualified because five of the seven platforms named it during ranking discovery, giving it a 71.4% platform share, an average listed rank of 3.2, and a best listed rank of 3 [1]. It cleared the study's minimum-mention threshold of two and finished as the fourth-ranked carrier in the final ordering.

Platforms placed it in the ranking for different reasons. OpenAI and Perplexity cited John Hancock's medically underwritten term and permanent products and its detailed cardiac underwriting materials [6]. Anthropic and Kimi pointed to its atrial fibrillation underwriting approach and Vitality program [7]. Grok cited documented experience underwriting cardiac impairments such as coronary artery disease, AFib, bypass, and angioplasty [4].

The fit ratings split: Anthropic, Google, and Kimi rated John Hancock a "good" fit, while DeepSeek, Grok, OpenAI, and Perplexity rated it "mixed." That split is itself a finding — the platforms agree John Hancock belongs in the comparison set but disagree on how strongly it should be recommended for this use case.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for People With Heart Disease

Questions This Section Answers

  • Which John Hancock plan should a buyer with heart disease choose: Vitality Term, Protection UL, or Simple Term with Vitality?
  • Does John Hancock's Simple Term with Vitality accept applicants with a heart attack or stent history?

The relevant John Hancock offering for this use case is medically underwritten term life insurance (including Vitality Term) or permanent life insurance (Protection UL), typically with optional John Hancock Vitality, evaluated through a licensed agent or independent broker [10]. John Hancock offers term coverage generally described as 10- to 30-year protection and permanent coverage designed for potentially lifetime protection with cash-value potential [13].

A critical distinction applies to cardiac applicants. John Hancock's published Simple Term with Vitality underwriting guide lists coronary or vascular disease, heart attack, stent placement, and cardiomyopathy as ineligible for that product [14]. That makes Simple Term with Vitality a poor match for many applicants with heart disease, even though the broader medically underwritten term and permanent lineup may still be available.

Platforms also flagged a product-naming conflict. The ranking-stage description referenced "Protection UL," while current public John Hancock materials also identify Protection IUL and, in 2026, Protection VUL; the exact product intended by "Protection UL" should be confirmed with the carrier or broker [14]. Buyers should verify the exact contract name before applying.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about John Hancock for heart disease life insurance?
  • Is John Hancock's Vitality program relevant to a buyer with a cardiac history?

The platforms reached strong agreement on four points.

First, John Hancock uses full medical underwriting that considers cardiac history rather than applying a blanket denial. John Hancock states that policy issuance is not guaranteed and may require health questions, underwriting approval, and medical records [15]. Its underwriting evaluates current health, medical history, lifestyle, and other risk factors to determine eligibility and premiums [16]. Independent sources describe John Hancock as flexible for pre-existing conditions, considering the applicant's entire life and health status rather than denying based solely on a condition [17].

Second, John Hancock's Vitality program is a genuine differentiator. Vitality PLUS offers up to 25% off premium for healthy choices [19], and can be added to eligible policies for as little as $2 per month for single-life permanent products [21]. In April 2026, John Hancock announced cardiac health support tools for Vitality members, including discounted access to in-home automated external defibrillators through GoRescue and offers on Garmin Index BPM blood pressure monitors [22].

Third, John Hancock is financially strong. It is rated A+ (Superior) by AM Best [24], and independent reviews place it among the more financially secure U.S. life insurers, with ratings similar to Prudential and Protective Life [25].

Fourth, term policies are convertible to permanent coverage without additional medical underwriting, which matters for a cardiac applicant who may not want to re-qualify later [26].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • Does John Hancock offer better rates for atrial fibrillation than other carriers?
  • Is John Hancock's pricing competitive for a cardiac applicant who receives a table rating?

The platforms disagreed on how favorable John Hancock's cardiac underwriting actually is, and the disagreement is material.

On atrial fibrillation, Anthropic and Kimi reported that John Hancock uses CHA2DS2-VASc stroke-risk scoring and may offer Standard rates for scores of 0-1, treating well-managed AFib with no structural heart disease as low risk [27]. Perplexity labeled a similar 2026 third-party claim as only partially verified [31]. No platform produced a John Hancock cardiac underwriting manual confirming these thresholds.

On table ratings, the evidence is mixed. In a documented case of a 64-year-old with a heart attack at 61, bypass surgery, and compliant cardiac workups, John Hancock assigned a Table 4 rating alongside Prudential, Protective, Banner Life, Lincoln Financial, and SBLI, while Corebridge achieved Standard [32]. Separately, independent sources state that John Hancock Vitality is not competitive for Standard risks, standard smoker risks, or table ratings because Hancock rates off its Standard rate class [35]. This conflicts with Kimi's claim that Vitality remains available to table-rated applicants with 10-15% premium returns [30]. Buyers should treat the table-rated Vitality benefit as unverified.

On pricing, independent reviews report that John Hancock's advantage narrows at $500,000 coverage and becomes 6%-7% above average at $1.5 million to $2 million [37]. One platform noted John Hancock's above-average pricing at high coverage amounts as a reason to consider competitors [38].

On accelerated underwriting, Perplexity found that publicly available summaries list coronary artery disease and related cardiovascular impairments among exclusions for no-exam eligibility [39]. John Hancock states that qualifying applicants may receive an underwriting decision without a traditional medical exam through ExpressTrack [41], but qualification is not established for applicants with heart disease.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • What cardiac-specific features does John Hancock offer for a buyer with heart disease?
  • Does John Hancock offer living benefits that pay out for a heart attack?

John Hancock's cardiac-relevant capabilities fall into four areas.

Medically underwritten term and permanent coverage. Term coverage ranges from $250,000 to $30 million for 10- to 30-year terms, and universal life coverage ranges from $50,000 to $65 million [42]. Whole life insurance is not offered [44].

Detailed cardiac underwriting. Public underwriting materials indicate John Hancock asks for detailed cardiac history and records, including attending physician statements, cardiac investigations, medications, activity level, and related test results [46]. Attending physician statements are required from a primary physician within the past 12-18 months, and exam, blood chemistry, EKG, and urinalysis may be requested at underwriter discretion [48].

Living benefits and riders. John Hancock offers optional Critical Illness Benefit and Long-Term Care riders on policies such as Protection UL and Term. The Critical Illness rider pays a tax-free lump sum up to $250,000 for covered conditions including heart attacks and coronary artery bypass grafts, subject to separate health classifications [51]. A 30-day waiting period applies to the Critical Illness Benefit rider from its effective date [53].

Vitality wellness features. Vitality PLUS offers up to 25% off premium for healthy choices [54]. John Hancock describes Vitality fees, premium savings potential, rewards, and the possibility that rewards and discounts may change [56]. The 2026 cardiac tools include discounted AED access and blood pressure monitors [57].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does John Hancock term life insurance cost per month for a 40-year-old nonsmoker?
  • What fees apply to John Hancock Vitality PLUS, and can rewards change after purchase?

No applicant-specific premium or cardiac underwriting offer is publicly verifiable for John Hancock. Pricing confidence across platforms is low to moderate, and every platform stated that cardiac pricing is underwriting-dependent and not published [59].

For context, independent reviews report a sample rate for a $100,000 John Hancock term policy of $9 per month for women and $11 per month for men, age 40, nonsmoker, 20-year term, described as 40%-43% below the national average [60]. Following 2026 rate reductions averaging 13% for ages 35-60 on amounts under $2 million, one review reports an average annual premium of approximately $349, about 9% below the industry average of $382 [65]. These figures describe healthy applicants, not cardiac applicants, and should not be read as cardiac pricing.

On fees, John Hancock states that Vitality PLUS may cost 3% of annual premium for term policies with the optional Vitality rider, while for single-life permanent products John Hancock states a $2-per-month rider fee; Vitality Term and Simple Term with Vitality may include the cost within the policy price [59]. Wearable-device programs may involve taxes, upgrade charges, installment payments, or other out-of-pocket costs [59]. Vitality rewards, discounts, and program terms may change and are not guaranteed for the life of the policy [68].

On contract terms, term coverage ends at the end of the term unless the contract provides renewal, conversion, or another continuation option, and renewal premiums may be higher [59]. Term policies are convertible to permanent coverage without additional underwriting before age 70 or the end of the level premium period [69]. Permanent-policy guarantees, non-guaranteed values, surrender charges, lapse risks, and loan provisions must be reviewed in the policy illustration and contract [59]. State availability and policy features vary, and John Hancock states that its New York issuing company differs from its other U.S. issuing company [59].

Best Suited For

Questions This Section Answers

  • Who is John Hancock best suited for among buyers with heart disease?
  • Is John Hancock a good fit for a buyer with well-managed atrial fibrillation?

John Hancock is best considered for applicants willing to complete full medical underwriting and provide cardiology records, testing, treatment, and medication information [70]. It suits applicants seeking term coverage for income replacement, mortgage protection, or other time-limited needs, and applicants seeking permanent coverage who understand the substantially higher premiums and policy-performance risks [70].

It also fits applicants who value optional Vitality rewards and can meet participation requirements [70]. Platforms specifically identified well-managed atrial fibrillation with low CHA2DS2-VASc scores as a profile where John Hancock may be competitive [71], and family history of early heart disease as another area where John Hancock may be more lenient than competitors [74].

Applicants ages 35-60 seeking term coverage under $2 million with an interest in wellness credits were also named as a fit profile [76].

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose John Hancock for life insurance with a heart disease history?
  • Is John Hancock a poor fit for a buyer who needs guaranteed-issue coverage?

John Hancock is probably not best for applicants seeking guaranteed acceptance or simplified issue despite a significant cardiac history [78]. It is also a weak fit for applicants with a recent heart attack, recent stent or cardiac procedure, active symptoms, unstable disease, or incomplete recommended testing [78].

Buyers who need a confirmed price or approval before medical underwriting should look elsewhere, because John Hancock's cardiac pricing is not published [78]. Buyers who want the lowest possible premium and do not value wellness-program features are also a poor match, since John Hancock's Vitality rates off its Standard rate class and is described as not competitive on table ratings [84].

Applicants with severe, unstable, or advanced cardiac conditions — including congestive heart failure, recent heart attacks within 12-24 months, or an ejection fraction below 40% — are generally postponed or declined for traditional coverage [86]. Smokers or applicants unwilling to modify tobacco use after a cardiac event are also a poor fit, since John Hancock rates tobacco use aggressively on cardiac cases [84].

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to John Hancock for a buyer with a recent heart attack or stent placement?
  • When should a cardiac applicant choose a guaranteed-issue carrier instead of John Hancock?

Another option may be better in several specific situations.

If the applicant had stent placement and qualifies within Lincoln Financial's favorable underwriting for stent patients two or more years post-event, Lincoln may be more appropriate [88]. If the cardiac event was very recent — less than six months — simplified or guaranteed-issue coverage may be preferable to standard underwriting with postponement, because medical exam approval is difficult within six months of a heart attack due to stability concerns [90].

If the buyer needs guaranteed-issue or final-expense coverage and accepts lower limits and higher cost, a specialized guaranteed-issue carrier may be more appropriate; Mutual of Omaha is cited for guaranteed-issue availability with age limits of 45-85 and graded-period terms [92]. If the buyer needs simplified underwriting and has a cardiac history that makes John Hancock's published Simple Term with Vitality rules inapplicable, another carrier may fit better [93].

If the buyer needs high coverage amounts of $2 million or more, John Hancock's above-average pricing at those levels makes competitors more attractive [94]. If the buyer seeks whole life insurance with guaranteed premiums and forced cash value accumulation, John Hancock does not offer that product [95]. If the buyer wants only low-cost temporary protection, another carrier may offer a better fully underwritten term quote after comparing equivalent terms and ratings [93].

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with John Hancock before signing a cardiac life insurance contract?
  • What cardiac testing will John Hancock require during underwriting?

Before applying, a buyer should confirm the following with John Hancock or an independent broker.

For the exact diagnosis, when was it diagnosed, and what underwriting class, rating, postponement, or decline is likely [97]? Will John Hancock require cardiology records, an attending-physician statement, ECG, echocardiogram, stress test, catheterization report, laboratory results, or additional testing [97]? How do prior heart attack, bypass surgery, angioplasty, stent placement, cardiomyopathy, arrhythmia, heart failure, valve disease, and current symptoms affect eligibility [97]?

Does the applicant qualify for standard medically underwritten term or permanent coverage even though Simple Term with Vitality is excluded for the relevant cardiac history [97]? What are the guaranteed premium schedule, renewal rates, conversion deadline, and available conversion products for the proposed term policy [97]? For permanent coverage, which values and benefits are guaranteed, what assumptions are non-guaranteed, and what happens if premiums are reduced, delayed, or stopped [97]?

What exact Vitality product, fee, savings formula, state restrictions, participation requirements, and change rights apply to the proposed policy [97]? Is the recommending agent captive to John Hancock or independent and able to compare multiple insurers' cardiac underwriting outcomes [97]? What exclusions, contestability terms, reinstatement provisions, suicide clause, riders, and free-look period apply in the buyer's state [97]? What is the total long-term cost under conservative and adverse policy-illustration assumptions [97]?

Final AI Consensus Verdict

John Hancock is a mixed fit for life insurance for people with heart disease. Five of seven platforms named it during ranking, with an average listed rank of 3.2 and a best rank of 3, and three platforms rated the fit "good" while four rated it "mixed." The strongest case for John Hancock is its medically underwritten term and permanent coverage, which can evaluate an actual cardiac history case by case, combined with a Vitality program that offers wellness rewards and, as of April 2026, cardiac-specific support tools [101].

The strongest case against is the absence of published cardiac-specific acceptance rules or rates, the explicit cardiac exclusions in Simple Term with Vitality [103], and independent evidence that John Hancock assigned a Table 4 rating in a documented post-bypass case where a competitor achieved Standard [104]. Approval and pricing for standard products remain uncertain until John Hancock reviews the applicant's complete medical profile.

The practical conclusion: John Hancock is worth a broker-assisted comparison for a consumer with stable heart disease who is prepared for full medical underwriting, particularly when term or permanent coverage and Vitality features are desired. It is not a strong fit for simplified-issue cardiac applicants. Buyers should compare it against the broader set of carriers covered in this Life Insurance for People With Heart Disease study before deciding.

How This Review Was Produced

This review was produced from a structured AI-platform research run dated 2026-09-22. Seven platforms evaluated John Hancock for the use case "Life Insurance for People With Heart Disease": Anthropic (claude-haiku-4-5-20251001), DeepSeek (deepseek-v4-flash), Google (gemini-3.5-flash), Grok (x-ai/grok-4.3), Kimi (moonshotai/kimi-k2.6), OpenAI (gpt-5.6-luna), and Perplexity (perplexity/sonar). Five of the seven named John Hancock during ranking discovery.

Each platform returned a fit rating, strengths, limitations, pricing and terms, and questions to verify before buying. All platform outputs are labeled platform-reported and were not independently verified by the writer stage. Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated.

Methodology Limitations

Several limitations apply to this review.

Platform-reported research dates differ from the authoritative run date. DeepSeek reported a research date of 2026-01-17, while the other six platforms reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness.

The deterministic identity audit contains qualification notes that must be disclosed. Conflicting official domains forced an unresolved identity, official-site retrieval failed for one or more mentions, and the identity used an exact-name fallback. The matching reported domain was retained for downstream research but remains unverified. The cited John Hancock pages themselves identify John Hancock insurance entities, but the identity issue should remain treated as something to verify.

John Hancock's public materials do not disclose a complete cardiac underwriting manual for standard term or permanent policies. No public source reviewed provides cardiac-specific acceptance rules, likely table ratings, postponement periods, or expected premiums for standard John Hancock products. A cardiac history may result in higher premiums, reduced coverage, postponement, or decline, and the outcome cannot be inferred from the company's general product pages.

Vitality pricing and eligibility differ by product and state, and some public pages describe included Vitality costs while others describe separate rider fees. The ranking-stage description references Protection UL, while current public John Hancock materials also identify Protection IUL and, in 2026, Protection VUL; the exact product intended by "Protection UL" should be confirmed.

Platform agreement does not prove product quality. The fit ratings split three "good" to four "mixed," and no platform conducted personal testing or verified customer experience. Buyers should treat all pricing figures as illustrative and confirm every cardiac-specific detail with a licensed agent or independent broker before applying. For broader context on coverage categories, see the life insurance directory.

Sources

Company-Owned Sources

Independent Sources

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 22, 2026
Platforms analyzed
7
Source records
46
Ranking mentions
5 of 7
Platform share
71%
Final consensus rank
#4

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

31 independent · 15 company-owned

Evidence support

42 direct · 4 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

5b39480a95a01a673e7cc8daa04c065c74a74349a1ad2a8ad5ea3be272c513b9